Roche China confirmed on July 12, 2012 that six of the eight medications, which are used to treat cancers and a liver disease, involved in the investigation are sold in China, instead of five.
The State Food and Drug Administration (SFDA) said Thursday that it has debriefed a manager supervising product security at Roche China, following an investigation into possible adverse reactions of some Roche products.
Go to Forum >>0 Comment(s)